Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson's Disease
Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson's Disease - Data from the company's CHELATE trial to be presented today during an oral presentation
Source: finanznachrichten.de